86 results
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
7 May 24
Rhythm Pharmaceuticals Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update
7:10am
Agreement, or RIFA, entered into with HealthCare Royalty Partners in June 2022.
Net Loss: Net loss was $(141.4) million for the three months ended … & Healthcare Products Regulatory Agency (MHRA) have authorized setmelanotide for the treatment of obesity and the control of hunger associated with genetically
8-K
EX-3.1
RYTM
Rhythm Pharmaceuticals Inc.
16 Apr 24
Entry into a Material Definitive Agreement
7:00am
Interest Financing Agreement, dated as of June 16, 2022, among Rhythm Pharmaceuticals, Inc., entities managed by Healthcare Royalty Management, LLC
8-K
EX-10.1
iqyd22 qejrwn4
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
8-K
EX-99.1
7ia94u9 3yjo2x6a7ez
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
424B5
26apz6
29 Feb 24
Prospectus supplement for primary offering
4:44pm
8-K
EX-99.1
dt1g wf4ur5541qh4p
22 Feb 24
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update
7:01am
8-K
90n30rkw3mk1vx 6c7
4 Jan 24
Entry into a Material Definitive Agreement
7:00am
8-K
u5jxe3hl8vtd1o0zc4
6 Dec 23
Other Events
4:30pm
8-K
EX-99.1
99pm 0w7x3nq16
7 Nov 23
Rhythm Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Update
7:05am
8-K
ya4fn f0qi8k
21 Aug 23
Other Events
4:30pm
8-K
EX-99.1
rh17z
1 Aug 23
Rhythm Pharmaceuticals Reports Second Quarter 2023 Financial Results and Business
7:05am
8-K
EX-99.1
zy0ysqmhx0bf1jv
2 May 23
Rhythm Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Update
7:05am